Study Evaluating Venlafaxine ER in Children and Adolescents With Social Anxiety Disorder
Status:
Completed
Trial end date:
2003-06-01
Target enrollment:
Participant gender:
Summary
To determine the anxiolytic efficacy, safety, and tolerability of a flexible-dose of
venlafaxine extended release (ER) administered for 16 weeks in the treatment of children and
adolescent outpatients with social anxiety disorder (generalized) in a placebo-controlled
study.